Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs
NCT ID: NCT03200535
Last Updated: 2019-12-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6588 participants
INTERVENTIONAL
2017-06-26
2017-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
Usual care
No interventions assigned to this group
Electronic health record "gaps"
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
EHR gaps
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
Bulk outreach
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient; in addition a bulk letter or email will be sent
EHR gaps
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
Bulk outreach
A bulk letter or email will be sent
Personalized outreach
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient; in addition a bulk letter or email will be sent and patients will receive a personalized call by a registered dietitian
EHR gaps
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
Bulk outreach
A bulk letter or email will be sent
Dietician call
Patients will receive a personalized call by a registered dietitian
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EHR gaps
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
Bulk outreach
A bulk letter or email will be sent
Dietician call
Patients will receive a personalized call by a registered dietitian
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-75
* Prediabetes
* BMI \>= 25
* A1c 6.1-6.4%
* No dietitian visit within the past 3 years
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emily Schroeder
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Schroeder, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Kaiser Permanente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Coloado
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CO-17-2437
Identifier Type: -
Identifier Source: org_study_id